NCT02614781已完成不适用
Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 892
- 试验地点
- 1
- 主要终点
- success rate of the protocol Mifegyne and prostaglandin analogue
研究概览
简要总结
This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers.
The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Adult women (≥ 18 years old) with confirmed intra-uterine pregnancy consulting for medical termination of pregnancy
- •Patients for whom the physician decides to use a Mifegyne 600 mg and prostaglandin analogue combination for medical abortion
- •Patients agreeing to participate in the study after having been informed orally by the physician and given the information sheet
- •Informed patients accepting the computer processing of their medical data and their right of access and correction
排除标准
- •Patients with known hypersensitivity to mifepristone
- •Patients with known hypersensitivity to prostaglandin analogues (misoprostol or gemeprost).
- •Patients with severe and progressive disease
- •Patients with ectopic pregnancy
结局指标
主要结局
success rate of the protocol Mifegyne and prostaglandin analogue
时间窗: At the follow-up at 2-3 weeks after inclusion
The success rate will be defined as complete abortion without surgical procedure
次要结局
- rate of ongoing pregnancy by term.(at the follow up at 2-3 weeks after the inclusion)
- Number of medical abortion using misoprostol(at the follow up at 2-3 weeks after the inclusion)
- Evaluation by patients of pain using a 5 level verbal rating scale(at the follow up at 2-3 weeks after the inclusion)
- rate of patients requiring any additional procedures by term.(at the follow up at 2-3 weeks after the inclusion)
- Success rate of the protocol Mifegyne and misoprostol per os.(at the follow up at 2-3 weeks after the inclusion)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECTDepressionNCT00285818Stanford University11
已完成
不适用
Study comparing two methods of abortion in second trimester using misoprostol or ethacridine lactate after priming with mifepristoneCTRI/2018/01/011157Project in the Department of Obstetrics and Gynecology120
已完成
2 期
Mifepristone (RU-486) in Androgen Independent Prostate CancerAdenocarcinoma of ProstateProstate CancerNCT00140478Dana-Farber Cancer Institute48
终止
2 期
Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung CancerNon-Small Cell Lung Cancer (NSCLC)NCT02642939Check, Jerome H., M.D., Ph.D.3
暂停
不适用
Medical methods for First trimester abortion upto 10weeksCTRI/2022/01/039355SDM College of medical sciences and hospital